This cellular subtype is considered to be a key player in the development of the disease, since myofibroblasts have a high capacity for synthesis and proliferation, and also produce very high levels of collagen type I. Therefore, this study suggests that ACTA2 transcript levels could be used as a potential biomarker for SSc [51]. Here, ACTA2 is linked to systemic sclerosis.